NCT01107080
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +13 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
Clinical trial condition
Breast Carcinoma In Situ
Explore clinical trials studying Breast Carcinoma In Situ. Study availability and eligibility vary by location and protocol.
151 public trials
22 recruiting studies
Breast Carcinoma In Situ trial results
NCT00262899
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +13 more
- Locations
-
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Chevy Chase, Maryland, United States
- Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
- Mount Sinai School of Medicine New York, United States
NCT00081965
- Conditions
- Breast Cancer, Breast Carcinoma In Situ, Breast Diseases, +12 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00416403
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- University of Chicago Cancer Research Center Chicago, Illinois, United States
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00002920
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +24 more
- Locations
-
- MBCCOP - Gulf Coast Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- CCOP - Western Regional, Arizona Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix, Arizona, United States
NCT00749437
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +14 more
- Locations
-
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States
Completed
Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers
NCT00225927
- Conditions
- Breast Cancer Invasive Nos, Breast Carcinoma In Situ, Breast Diseases, +10 more
- Locations
-
- St. Joseph's Healthcare Hamilton, Ontario, Canada
- Juravinski Cancer Centre Hamilton, Ontario, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
NCT00084669
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT00388115
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
- Locations
-
- University of California Davis Cancer Center Sacramento, California, United States
Active, Not Recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
NCT02954874
- Conditions
- Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States